Verastem, Inc. (VSTM) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
29/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseVSTM / S&P -27.92% / 15.20% |
LoseVSTM / S&P VSTM unavailable / 15.00% |
LoseVSTM / S&P -34.32% / 50.40% |
| 2026-Q10/3 |
LoseVSTM / S&P -31.35% / -4.33% |
LoseVSTM / S&P VSTM unavailable / 11.30% |
LoseVSTM / S&P -20.47% / 27.70% |
| 2025-Q40/3 |
LoseVSTM / S&P -12.57% / 2.65% |
LoseVSTM / S&P VSTM unavailable / 9.00% |
LoseVSTM / S&P -13.44% / 13.40% |
| 2025-Q32/3 |
WinVSTM / S&P 112.77% / 8.12% |
LoseVSTM / S&P VSTM unavailable / 4.61% |
WinVSTM / S&P 40.00% / 13.45% |
| 2025-Q21/3 |
LoseVSTM / S&P -31.18% / 10.94% |
LoseVSTM / S&P VSTM unavailable / 4.83% |
WinVSTM / S&P 11.34% / 10.63% |
| 2025-Q11/3 |
WinVSTM / S&P 16.63% / -4.27% |
LoseVSTM / S&P VSTM unavailable / 4.98% |
LoseVSTM / S&P -22.45% / 10.57% |
| 2024-Q42/3 |
WinVSTM / S&P 72.91% / 2.41% |
LoseVSTM / S&P VSTM unavailable / 5.25% |
WinVSTM / S&P 15.17% / 6.15% |
| 2024-Q30/3 |
LoseVSTM / S&P 0.34% / 5.89% |
LoseVSTM / S&P VSTM unavailable / 5.89% |
LoseVSTM / S&P -50.54% / 6.11% |
| 2024-Q20/3 |
LoseVSTM / S&P -74.75% / 4.28% |
LoseVSTM / S&P VSTM unavailable / 5.38% |
LoseVSTM / S&P -42.34% / 5.12% |
| 2024-Q11/3 |
WinVSTM / S&P 44.96% / 10.56% |
LoseVSTM / S&P VSTM unavailable / 5.71% |
LoseVSTM / S&P -3.29% / 5.59% |
| 2023-Q40/3 |
LoseVSTM / S&P 0.12% / 11.69% |
LoseVSTM / S&P VSTM unavailable / 6.81% |
LoseVSTM / S&P -29.32% / 7.78% |
| 2023-Q32/3 |
WinVSTM / S&P 9.27% / -3.27% |
LoseVSTM / S&P VSTM unavailable / 7.52% |
WinVSTM / S&P 32.31% / -5.03% |
| 2023-Q22/3 |
WinVSTM / S&P 47.62% / 8.74% |
LoseVSTM / S&P VSTM unavailable / 9.50% |
WinVSTM / S&P 17.85% / -8.57% |
| 2023-Q11/3 |
LoseVSTM / S&P 5.00% / 7.50% |
LoseVSTM / S&P VSTM unavailable / 10.77% |
WinVSTM / S&P -7.13% / -15.69% |
| 2022-Q41/3 |
LoseVSTM / S&P -52.94% / 7.56% |
LoseVSTM / S&P VSTM unavailable / 11.88% |
WinVSTM / S&P -6.92% / -17.99% |
| 2022-Q31/3 |
LoseVSTM / S&P -26.72% / -4.88% |
LoseVSTM / S&P VSTM unavailable / 13.47% |
WinVSTM / S&P 1011.36% / -1.41% |
| 2022-Q21/3 |
LoseVSTM / S&P -17.73% / -16.10% |
LoseVSTM / S&P VSTM unavailable / 13.71% |
WinVSTM / S&P 2043.48% / 11.04% |
| 2022-Q10/3 |
LoseVSTM / S&P -31.22% / -4.60% |
LoseVSTM / S&P -95.69% / 15.97% |
LoseVSTM / S&P VSTM unavailable / 42.23% |
| 2021-Q40/3 |
LoseVSTM / S&P -33.44% / 11.03% |
LoseVSTM / S&P -97.68% / 15.00% |
LoseVSTM / S&P VSTM unavailable / 96.40% |
| 2021-Q30/3 |
LoseVSTM / S&P -24.32% / 0.58% |
LoseVSTM / S&P -97.80% / 10.77% |
LoseVSTM / S&P VSTM unavailable / 69.42% |
| 2021-Q22/3 |
WinVSTM / S&P 64.78% / 8.55% |
WinVSTM / S&P 266.45% / 6.58% |
LoseVSTM / S&P VSTM unavailable / 51.81% |
| 2021-Q12/3 |
WinVSTM / S&P 15.96% / 6.17% |
WinVSTM / S&P 305.31% / -1.06% |
LoseVSTM / S&P VSTM unavailable / 7.39% |
| 2020-Q42/3 |
WinVSTM / S&P 76.03% / 12.15% |
WinVSTM / S&P 407.11% / -3.72% |
LoseVSTM / S&P VSTM unavailable / -33.42% |
| 2020-Q31/3 |
LoseVSTM / S&P -29.65% / 8.93% |
WinVSTM / S&P 508.85% / -2.04% |
LoseVSTM / S&P VSTM unavailable / -27.10% |
| 2020-Q21/3 |
LoseVSTM / S&P -34.85% / 20.54% |
WinVSTM / S&P 2.26% / -0.46% |
LoseVSTM / S&P VSTM unavailable / -27.11% |
| 2020-Q11/3 |
WinVSTM / S&P 97.01% / -19.60% |
LoseVSTM / S&P -26.59% / 3.47% |
LoseVSTM / S&P VSTM unavailable / -14.75% |
| 2019-Q41/3 |
WinVSTM / S&P 10.74% / 9.07% |
LoseVSTM / S&P VSTM unavailable / 5.36% |
LoseVSTM / S&P VSTM unavailable / 2.99% |
| 2019-Q30/3 |
LoseVSTM / S&P -19.87% / 1.70% |
LoseVSTM / S&P VSTM unavailable / 5.02% |
LoseVSTM / S&P VSTM unavailable / 0.21% |
| 2019-Q20/3 |
LoseVSTM / S&P -48.99% / 4.30% |
LoseVSTM / S&P VSTM unavailable / 6.64% |
LoseVSTM / S&P VSTM unavailable / 8.65% |
| 2019-Q10/3 |
LoseVSTM / S&P -11.90% / 13.65% |
LoseVSTM / S&P VSTM unavailable / 8.12% |
LoseVSTM / S&P VSTM unavailable / 14.29% |
| 2018-Q40/3 |
LoseVSTM / S&P -53.66% / -13.52% |
LoseVSTM / S&P VSTM unavailable / 9.05% |
LoseVSTM / S&P VSTM unavailable / 18.23% |
| 2018-Q30/3 |
LoseVSTM / S&P 5.38% / 7.71% |
LoseVSTM / S&P VSTM unavailable / 10.21% |
LoseVSTM / S&P VSTM unavailable / 19.06% |
| 2018-Q21/3 |
WinVSTM / S&P 130.87% / 3.43% |
LoseVSTM / S&P VSTM unavailable / 9.03% |
LoseVSTM / S&P VSTM unavailable / 14.46% |
| 2018-Q10/3 |
LoseVSTM / S&P -2.93% / -0.76% |
LoseVSTM / S&P VSTM unavailable / 7.68% |
LoseVSTM / S&P VSTM unavailable / 12.46% |
| 2017-Q40/3 |
LoseVSTM / S&P -34.68% / 6.64% |
LoseVSTM / S&P VSTM unavailable / 7.03% |
LoseVSTM / S&P VSTM unavailable / 13.82% |
| 2017-Q31/3 |
WinVSTM / S&P 115.60% / 4.48% |
LoseVSTM / S&P VSTM unavailable / 5.68% |
LoseVSTM / S&P VSTM unavailable / 17.57% |
| 2017-Q21/3 |
WinVSTM / S&P 5.31% / 3.09% |
LoseVSTM / S&P VSTM unavailable / 4.83% |
LoseVSTM / S&P VSTM unavailable / 17.74% |
| 2017-Q11/3 |
WinVSTM / S&P 84.82% / 6.07% |
LoseVSTM / S&P VSTM unavailable / 3.67% |
LoseVSTM / S&P VSTM unavailable / 13.32% |
| 2016-Q40/3 |
LoseVSTM / S&P -15.79% / 3.82% |
LoseVSTM / S&P VSTM unavailable / 2.09% |
LoseVSTM / S&P VSTM unavailable / 7.05% |
| 2016-Q30/3 |
LoseVSTM / S&P 2.31% / 3.85% |
LoseVSTM / S&P VSTM unavailable / 0.20% |
LoseVSTM / S&P VSTM unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | VSTM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -20.22% | 20.78% |
| Annualized return | -20.22% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | VSTM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -77.05% | 83.14% |
| Annualized return | -25.50% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | VSTM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -54.10% | 319.30% |
| Annualized return | -7.49% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |